Statera Biopharma Inc. [STAB] Revenue clocked in at $0.20 million, down -85.46% YTD: What’s Next?

Related

Statera Biopharma Inc. [NASDAQ: STAB] slipped around -0.05 points on Friday, while shares priced at $0.33 at the close of the session, down -12.00%.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

Statera Biopharma Inc. stock is now -85.46% down from its year-to-date (YTD) trading value. STAB Stock saw the intraday high of $0.3611 and lowest of $0.305 per share. The company’s 52-week high price is 7.10, which means current price is +65.68% above from all time high which was touched on 01/03/22.

Compared to the average trading volume of 7.31M shares, STAB reached a trading volume of 21053911 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Statera Biopharma Inc. [STAB]?

The Average True Range (ATR) for Statera Biopharma Inc. is set at 0.06, with the Price to Sales ratio for STAB stock in the period of the last 12 months amounting to 94.86. The Price to Book ratio for the last quarter was 0.12, with the Price to Cash per share for the same quarter was set at 0.17.

How has STAB stock performed recently?

Statera Biopharma Inc. [STAB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 34.88. With this latest performance, STAB shares gained by 5.25% in over the last four-week period, additionally sinking by -90.63% over the last 6 months – not to mention a drop of -94.19% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for STAB stock in for the last two-week period is set at 48.13, with the RSI for the last a single of trading hit 56.11, and the three-weeks RSI is set at 42.01 for Statera Biopharma Inc. [STAB]. The present Moving Average for the last 50 days of trading for this stock 0.4725, while it was recorded at 0.2722 for the last single week of trading, and 2.2662 for the last 200 days.

Statera Biopharma Inc. [STAB]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Statera Biopharma Inc. [STAB] shares currently have an operating margin of -2057.00 and a Gross Margin at +67.16. Statera Biopharma Inc.’s Net Margin is presently recorded at -2346.46.

Statera Biopharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.

Insider trade positions for Statera Biopharma Inc. [STAB]

There are presently around $1 million, or 3.30% of STAB stock, in the hands of institutional investors. The top three institutional holders of STAB stocks are: VANGUARD GROUP INC with ownership of 417,359, which is approximately -2.107% of the company’s market cap and around 25.03% of the total institutional ownership; SABBY MANAGEMENT, LLC, holding 384,597 shares of the stock with an approximate value of $0.13 million in STAB stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $69000.0 in STAB stock with ownership of nearly 80.419% of the company’s market capitalization.

Positions in Statera Biopharma Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 16 institutional holders increased their position in Statera Biopharma Inc. [NASDAQ:STAB] by around 495,003 shares. Additionally, 9 investors decreased positions by around 449,156 shares, while 7 investors held positions by with 702,907 shares. The mentioned changes placed institutional holdings at 1,647,066 shares, according to the latest SEC report filing. STAB stock had 5 new institutional investments in for a total of 182,792 shares, while 6 institutional investors sold positions of 428,176 shares during the same period.